Pcx-flox 基因敲除小鼠

1. Huang, Zheng, Huang, Yanke, He, Hongtao, Ni, Jiangdong. 2015. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling. In Molecular medicine reports, 12, 3916-3922. doi:10.3892/mmr.2015.3859. https://pubmed.ncbi.nlm.nih.gov/26017117/

2. Tang, Weimin, Chen, Yi, Jang, Hee-Seong, Padanilam, Babu J, Oupický, David. 2021. Preferential siRNA delivery to injured kidneys for combination treatment of acute kidney injury. In Journal of controlled release : official journal of the Controlled Release Society, 341, 300-313. doi:10.1016/j.jconrel.2021.11.029. https://pubmed.ncbi.nlm.nih.gov/34826532/

3. Heng, Sophea, Samarajeewa, Nirukshi, Wang, Yao, Breen, James, Nie, Guiying. 2021. Podocalyxin promotes an impermeable epithelium and inhibits pro-implantation factors to negatively regulate endometrial receptivity. In Scientific reports, 11, 24016. doi:10.1038/s41598-021-03425-2. https://pubmed.ncbi.nlm.nih.gov/34907278/